218 related articles for article (PubMed ID: 9677338)
1. ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.
Hellyer NJ; Cheng K; Koland JG
Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):757-63. PubMed ID: 9677338
[TBL] [Abstract][Full Text] [Related]
2. Heregulin-dependent activation of phosphoinositide 3-kinase and Akt via the ErbB2/ErbB3 co-receptor.
Hellyer NJ; Kim MS; Koland JG
J Biol Chem; 2001 Nov; 276(45):42153-61. PubMed ID: 11546794
[TBL] [Abstract][Full Text] [Related]
3. Yeast two-hybrid in vivo association of the Src kinase Lyn with the proto-oncogene product Cbl but not with the p85 subunit of PI 3-kinase.
Dombrosky-Ferlan PM; Corey SJ
Oncogene; 1997 May; 14(17):2019-24. PubMed ID: 9160881
[TBL] [Abstract][Full Text] [Related]
4. Novel mechanism of interaction of p85 subunit of phosphatidylinositol 3-kinase and ErbB3 receptor-derived phosphotyrosyl peptides.
Suenaga A; Takada N; Hatakeyama M; Ichikawa M; Yu X; Tomii K; Okimoto N; Futatsugi N; Narumi T; Shirouzu M; Yokoyama S; Konagaya A; Taiji M
J Biol Chem; 2005 Jan; 280(2):1321-6. PubMed ID: 15520002
[TBL] [Abstract][Full Text] [Related]
5. T cell activation induces direct binding of the Crk adapter protein to the regulatory subunit of phosphatidylinositol 3-kinase (p85) via a complex mechanism involving the Cbl protein.
Gelkop S; Babichev Y; Isakov N
J Biol Chem; 2001 Sep; 276(39):36174-82. PubMed ID: 11418612
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
[TBL] [Abstract][Full Text] [Related]
7. ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor.
Soltoff SP; Carraway KL; Prigent SA; Gullick WG; Cantley LC
Mol Cell Biol; 1994 Jun; 14(6):3550-8. PubMed ID: 7515147
[TBL] [Abstract][Full Text] [Related]
8. p85 subunit of PI3 kinase does not bind to human Flt3 receptor, but associates with SHP2, SHIP, and a tyrosine-phosphorylated 100-kDa protein in Flt3 ligand-stimulated hematopoietic cells.
Zhang S; Broxmeyer HE
Biochem Biophys Res Commun; 1999 Jan; 254(2):440-5. PubMed ID: 9918857
[TBL] [Abstract][Full Text] [Related]
9. Cloning of the rat ErbB3 cDNA and characterization of the recombinant protein.
Hellyer NJ; Kim HH; Greaves CH; Sierke SL; Koland JG
Gene; 1995 Nov; 165(2):279-84. PubMed ID: 8522190
[TBL] [Abstract][Full Text] [Related]
10. Structural and thermodynamic characterization of the interaction of the SH3 domain from Fyn with the proline-rich binding site on the p85 subunit of PI3-kinase.
Renzoni DA; Pugh DJ; Siligardi G; Das P; Morton CJ; Rossi C; Waterfield MD; Campbell ID; Ladbury JE
Biochemistry; 1996 Dec; 35(49):15646-53. PubMed ID: 8961927
[TBL] [Abstract][Full Text] [Related]
11. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
Susa M; Rohner D; Bichsel S
Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
[TBL] [Abstract][Full Text] [Related]
12. YXXM motifs in the PDGF-beta receptor serve dual roles as phosphoinositide 3-kinase binding motifs and tyrosine-based endocytic sorting signals.
Wu H; Windmiller DA; Wang L; Backer JM
J Biol Chem; 2003 Oct; 278(42):40425-8. PubMed ID: 12941951
[TBL] [Abstract][Full Text] [Related]
13. Heregulin-stimulated signaling in rat pheochromocytoma cells. Evidence for ErbB3 interactions with Neu/ErbB2 and p85.
Gamett DC; Greene T; Wagreich AR; Kim HH; Koland JG; Cerione RA
J Biol Chem; 1995 Aug; 270(32):19022-7. PubMed ID: 7642563
[TBL] [Abstract][Full Text] [Related]
14. Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis.
Smirnova T; Zhou ZN; Flinn RJ; Wyckoff J; Boimel PJ; Pozzuto M; Coniglio SJ; Backer JM; Bresnick AR; Condeelis JS; Hynes NE; Segall JE
Oncogene; 2012 Feb; 31(6):706-15. PubMed ID: 21725367
[TBL] [Abstract][Full Text] [Related]
15. Identification of two SH3-binding motifs in the regulatory subunit of phosphatidylinositol 3-kinase.
Kapeller R; Prasad KV; Janssen O; Hou W; Schaffhausen BS; Rudd CE; Cantley LC
J Biol Chem; 1994 Jan; 269(3):1927-33. PubMed ID: 8294442
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product.
Kim HH; Sierke SL; Koland JG
J Biol Chem; 1994 Oct; 269(40):24747-55. PubMed ID: 7929151
[TBL] [Abstract][Full Text] [Related]
17. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
[TBL] [Abstract][Full Text] [Related]
18. The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of phosphatidylinositol 3-kinase to phosphorylated platelet-derived growth factor beta receptor.
Klippel A; Escobedo JA; Fantl WJ; Williams LT
Mol Cell Biol; 1992 Apr; 12(4):1451-9. PubMed ID: 1312663
[TBL] [Abstract][Full Text] [Related]
19. Using a phage display library to identify basic residues in A-Raf required to mediate binding to the Src homology 2 domains of the p85 subunit of phosphatidylinositol 3'-kinase.
King TR; Fang Y; Mahon ES; Anderson DH
J Biol Chem; 2000 Nov; 275(46):36450-6. PubMed ID: 10967104
[TBL] [Abstract][Full Text] [Related]
20. Controlled overexpression of selected domains of the P85 subunit of phosphatidylinositol 3-kinase reverts v-Ha-Ras transformation.
Zhang QX; Davis ID; Baldwin GS
Biochim Biophys Acta; 1996 Jul; 1312(3):207-14. PubMed ID: 8703989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
